NIH Announces Restructured HIV Clinical Trials Networks
12-3-2020Cross-posted from NIAID NewsroomGrant Awards Set Stage for Next Seven Years of Science-Driven HIV Clinical ResearchThe National Institute of Allergy and Infec…
NIAID Newsroom
NIH Study Finds Long-Acting Injectable Drug Prevents HIV Acquisition in Cisgender Women
11-9-2020Cross-posted from NIAID NewsroomLong-Acting Regimen More Effective than Daily Oral Pill Among African WomenA pre-exposure prophylaxis (PrEP) regimen containing …
Vaginal Ring for HIV Prevention Receives Positive Opinion from European Regulator
7-24-2020Cross-posted from NIAID NewsroomNIAID Celebrates Pivotal Step Toward Expanding HIV Prevention Choices for WomenToday the European Medicines Agency (EMA) announc…
Kidney Transplantation Between People with HIV is Safe, NIH Study Finds
7-24-2020Cross-posted from NIAID NewsroomMulticenter HOPE Act Study Expands Pool of Available KidneysKidney transplantation from deceased donors with HIV to people livin…
NIAID and Partners to Develop Antibody-Based Products for HIV Prevention and Treatment
7-21-2020Cross-posted from NIAID NewsroomThe National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and IAVI, a nonprofit scie…
Long-Acting Injectable Form of HIV Prevention Outperforms Daily Pill in NIH Study
7-7-2020Cross-posted from NIAID NewsroomBoth Methods Highly Effective at Preventing HIV Among Men Who Have Sex with Men and Transgender WomenA pre-exposure prophylaxis …
NIH Study: Long-Acting Injectable Drug Prevents HIV Among Men Who Have Sex with Men, and Transgender Women
5-18-2020Cross-posted from NIAID NewsroomNIH Study is First Large Trial to Find Long-Acting HIV Prevention Highly Effective--Companion Study in Women Is OngoingAn invest…
NIAID Observes HIV Vaccine Awareness Day 2020
5-18-2020NIAID honors ongoing efforts to develop a safe, effective and durable HIV vaccine while scientists also research coronavirus disease 2019 (COVID-19).
NIH-Funded AIDS Clinical Trials Group Conducts COVID-19 Treatment Study
5-15-2020Cross-posted from NIAID NewsroomStudy Enrolling Adults with Mild to Moderate COVID-19 in the United States.Adults interested in participating in the trial shoul…
Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy
3-11-2020Cross-posted from NIAID NewsroomDolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women.The antiretrov…